Expert Perspectives on the Diagnosis and Proactive Management of Metabolic Dysfunction-Associated Steatohepatitis

Nov 07 2025
Convention Center: Room 147, Level 1
12:30 PM - 2:00 PM

World Class Speakers

Naim Alkhouri, MD, FAASLD
Industry Presenter

Naim Alkhouri, MD, FAASLD

Summit Clinical Research
Sonal Kumar, MD
Industry Presenter

Sonal Kumar, MD

Description

This interactive symposium will enhance knowledge of MASH diagnosis, risk stratification, and treatment. Expert-led sessions will review noninvasive diagnostic tools, guideline-driven staging, lifestyle interventions, and emerging therapies. Case-based discussions will engage learners in applying concepts to clinical scenarios and addressing real-world challenges in the diagnosis and proactive management of MASH.



Supported by: Novo Nordisk

Organized by: Med Learning Group 

Journey Maps

Objectives

  • Implement AASLD guideline recommendations to enable early MASH diagnosis, including MASH screening for at-risk individuals and the use of non-invasive diagnostic techniques, such as biomarker- and imaging-based testing.
  • Incorporate AASLD guideline recommendations for the medical management of MASH, including lifestyle modification and pharmacologic management recommendations, into clinical practice.
  • Analyze the efficacy and safety data from MASH clinical trials evaluating treatment with resmetirom or GLP-1 RAs for patients with MASH to inform the development of patient-centric, evidence-based treatment plans.